Text Size
13 studies found for:    FDOPA

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Phase II Safety and Efficacy Study of F-DOPA PET/CT in Children With Hyperinsulinemic Hypoglycemia
Conditions: Congenital Hyperinsulinism;   Persistent Hyperinsulinemic Hypoglycemia of Infancy;   Pancreatectomy
Intervention: Drug: 18 F-DOPA PET/CT imaging
2 Recruiting Positron Emission Tomography (PET) With 3,4-dihydroxy-6-18F-fluoro-L-enylalanine (18F-FDOPA) Study
Condition: High-grade Glioma
Intervention: Procedure: Surgical neuronavigation with 18F-DOPA PET imaging
3 Active, not recruiting Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
Conditions: Congenital Hyperinsulinism;   Hyperinsulinism;   Persistent Hyperinsulinemic Hypoglycemia of Infancy;   CHI;   PHHI
Interventions: Drug: F-DOPA;   Radiation: PET scan
4 Recruiting Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
Conditions: Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Diffuse Astrocytoma;   Adult Ependymoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Mixed Glioma;   Adult Myxopapillary Ependymoma;   Adult Oligodendroglioma;   Adult Pilocytic Astrocytoma;   Adult Pineal Gland Astrocytoma;   Adult Subependymal Giant Cell Astrocytoma;   Adult Subependymoma
Interventions: Procedure: biopsy;   Procedure: computed tomography;   Procedure: therapeutic conventional surgery;   Radiation: radiation therapy treatment planning/simulation;   Radiation: radiation therapy;   Procedure: magnetic resonance imaging;   Procedure: positron emission tomography;   Drug: fluorine F 18 fluorodopa
5 Recruiting Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
Conditions: Glioma;   Glioblastoma
Intervention: Drug: FDOPA PET/CT
6 Completed Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's Disease
Condition: Parkinson Disease
Intervention: Drug: SR57667B
7 Terminated Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer
Conditions: Thyroid Neoplasm;   Thyroid Carcinoma;   Medullary Carcinoma
Intervention: Other: 18F-L-DOPA PET
8 Withdrawn [F-18]Fluoro-DOPA PET Imaging of Brain Tumors in Children
Condition: Brain Tumors
Intervention: Drug: [F-18]Fluoro-DOPA PET, a diagnostic radiopharmaceutical
9 Unknown † Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
Conditions: Amphetamine-Related Disorders;   Tobacco Use Disorder
Intervention:
10 Completed Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Cabergoline;   Drug: Levodopa
11 Recruiting Neuroimaging Of Treatment Effects in Treatment-Resistant Depression
Condition: Major Depressive Disorder
Intervention: Drug: escitalopram and adjunctive aripiprazole and placebo
12 Completed Relationship of Dopamine to Cognitive Function in Parkinson's Disease
Condition: Parkinson Disease
Intervention:
13 Recruiting PET Scanning in Parkinson's Disease
Condition: Parkinson's Disease
Intervention:
To Top

† Indicates status has not been verified in more than two years